Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RGS22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FBXO43 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLR2K - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COX6C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPAG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF19A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD46 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAPDHP62 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS13B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OSR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on